Home › Research › Topics › amyloid
amyloid
8 studies tagged amyloid, dated 2012-01-01 to 2025-07-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
Studies
8 studies carry this tag.
Date range
2012 to 2025
Top journals
- Neurobiology of aging 2
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- Brain : a journal of neurology 1
- CPT: pharmacometrics & systems pharmacology 1
- Frontiers in aging neuroscience 1
7 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Although APOE4 is strongly associated with amyloid-β (Aβ), its relationship with tau accumulation is less understood.
-
47/100
One-hundred-thirthy-three participants, namely 55 A+T+N+ AD, 28 Neurodegenerative disorders (NDD) and 50 controls were enrolled for the study.
-
The mechanisms by which the apolipoprotein E ε4 (APOEε4) allele influences the pathophysiological progression of Alzheimer's disease (AD) are poorly understood.
-
Lecanemab is a humanized immunoglobulin G1 monoclonal antibody that selectively binds to soluble Aβ aggregate species, while demonstrating low affinity for Aβ monomer.
-
Assay drift may reduce statistical power or even confound analyses.
-
Pathological hallmarks indicative of Alzheimer's disease (AD), which are the plaques of amyloid beta1-42 and neurofibrillary tangles, were found in brain of aged cynomolgus monkey.
-
36/100
Cellular studies suggest sphingolipids may cause or accelerate amyloid-beta (Aβ) and tau pathology but in vivo human studies are lacking.
-
Alzheimer's disease (AD) is characterized by a progressive cognitive impairment tightly correlated with the accumulation of amyloid-β (Aβ) peptides (mainly Aβ(1-42)).